Evaluating the impact of community-based treatment options on methamphetamine use: Findings from the Methamphetamine Treatment Evaluation Study (MATES)

Addiction

Volumn 107, Issue 11, 2012, Pages 1998-2008

  McKetin, Rebecca ^a,b   Najman, Jake M ^c   Baker, Amanda L ^d   Lubman, Dan I ^e   Dawe, Sharon ^f   Ali, Robert ^g   Lee, Nicole K ^h,i   Mattick, Richard P ^b   Mamun, Abdullah ^c  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f GRIFFITH UNIVERSITY   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h FLINDERS UNIVERSITY   (Australia)

ⁱ CURTIN UNIVERSITY   (Australia)

Author keywords

Amphetamine; Crime; HIV risk; Longitudinal; Methamphetamine; Outcomes; Psychiatric comorbidity; Substance abuse; Treatment

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CASE CONTROL STUDY; DRUG ABUSE; EVALUATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; RECURRENT DISEASE; RESIDENTIAL CARE; TREATMENT OUTCOME;

ADULT; AMPHETAMINE-RELATED DISORDERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHAMPHETAMINE; RECURRENCE; RESIDENTIAL TREATMENT; TREATMENT OUTCOME;

EID: 84867219650     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03933.x     Document Type: Article

References (36)

1. Nicosia N., Liccardo Pacula R., Kilmer B., Lundberg R., Chiesa J. The Economic Cost of Methamphetamine Use in the United States, 2005. Los Angeles, CA: RAND Drug Policy Research Center, Rand Corporation; 2009.
2. Colfax G., Santos G.-M., Chu P., Vittinghoff E., Pluddemann A., Kumar S. etal. Amphetamine-group substances and HIV. Lancet 2010; 376: 458-474.
3. Rawson R. A., Marinelli-Casey P., Anglin M. D., Dickow A., Frazier Y., Gallagher C. etal. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004; 99: 708-717.
4. Teesson M., Mills K., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008; 103: 80-88.
5. Gossop M., Marsden J., Stewart D., Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5 years' follow-up results. Addiction 2003; 98: 291-303.
6. Hubbard R. L., Craddock S. G., Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003; 25: 125-134.
7. Zweben J. E., Cohen J. B., Christian D., Galloway G. P., Salinardi M., Parent D. etal. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13: 181-190.
8. Glasner-Edwards S., Marinelli-Casey P., Hillhouse M., Ang A., Mooney L. J., Rawson R. for the Methamphetamine Treatment Project. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. J Nerv Ment Dis 2009; 197: 225-231.
9. Glasner-Edwards S., Mooney L. J., Marinelli-Casey P., Hillhouse M., Ang A., Rawson R. for the Methamphetamine Treatment Project. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. J Subst Abuse Treat 2008; 35: 445-450.
10. Glasner-Edwards S., Mooney L. J., Marinelli-Casey P., Hillhouse M., Ang A., Rawson R. for the Methamphetamine Treatment Project. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict 2010; 19: 385-390.
11. Wright S., Klee H., Reid P. Attitudes of amphetamine users towards treatment services. Drugs Educ Prev Policy 1999; 6: 71-86.
12. United Nations Office on Drugs and Crime. World Drug Report 2010. New York: United Nations; 2010.
13. Höfler M. Causal inference based on counterfactuals. BMC Med Res Methodol 2005; 5: 28.
14. Robins J., Hernan M., Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560.
15. Curtis L. H., Hammill B. G., Eisenstein E. L., Kramer J. M., Using A. K. J. Inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007; 45: S103-107.
16. Lipkovich I., Adams D. H., Mallinckrodt C., Faries D., Baron D., Houston J. P. Evaluating dose response from flexible dose clinical trials. BMC Psychiatry 2008; 8: 3.
17. Lee S.-W., Park S.-W., Yun S.-C., Kim Y.-H., Park D.-W., Kim W.-J. etal. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: drug-eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Am Heart J 2010; 159: 284-291. e281.
18. Nishida Y., Takahashi Y., Nakayama T., Soma M., Kitamura N., Asai S. Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records. Cardiovasc Diabetol 2010; 9: 38.
19. Australian Institute of Health and Welfare. Alcohol and Other Drug Treatment Services National Minimum Data Set 2011-12 Specifications and Collection Manual. Canberra: Australian Institute of Health and Welfare; 2011, p. 1-183.
20. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W. etal. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607-614.
21. Topp L., Mattick R. P. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997; 92: 839-845.
22. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992; 87: 733-742.
23. Rollnick S., Heather N., Gold R., Hall W. Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. B J Addict 1992; 87: 743-754.
24. Andrews G., Peters L. The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 80-88.
25. Robins L. N., Helzer J. E., Ratcliff K. S., Seyfried W. Validity of the diagnostic interview schedule, version II: DSM-III diagnoses. Psychol Med 1982; 12: 855-870.
26. Royston P. Multiple imputation of missing values: update. Stata J 2005; 5: 1-14.
27. Flynn P. M., Kristiansen P. L., Porto J. V., Hubbard R. L. Costs and benefits of treatment for cocaine addiction in DATOS. Drug Alcohol Depend 1999; 57: 167-174.
28. Godfrey C., Stewart D., Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction 2004; 99: 697-707.
29. Cartwright W. S. Cost-benefit analysis of drug treatment services: review of the literature. J Ment Health Policy Econ 2000; 3: 11-26.
30. Hartz D. T., Frederick-Osborne S. L., Galloway G. P. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend 2001; 63: 269-276.
31. Brecht M. L., von Mayrhauser C., Anglin M. D. Predictors of relapse after treatment for methamphetamine use. J Psychoact Drugs 2000; 32: 211-220.
32. Phillips B., Burns L. NSW Drug Trends 2009: Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trend Series no. 38. Sydney (Australia): National Drug and Alcohol Research Centre, University of New South Wales; 2010.
33. Austin P. C. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med 2010; 29: 2137-2148.
34. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998; 51: 253-263.
35. Miyaguchi H., Kakuta M., Iwata Y. T., Matsuda H., Tazawa H., Kimura H. etal. Development of a micropulverized extraction method for rapid toxicological analysis of methamphetamine in hair. J Chromatogr 2007; 1163: 43-48.
36. Wennig R. Potential problems with the interpretation of hair analysis results. Forensic Sci Int 2000; 107: 5-12.